255 related articles for article (PubMed ID: 37547182)
1. Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation.
Joseph J; Premeaux TA; Pinto DO; Rao A; Guha S; Panfil AR; Carey AJ; Ndhlovu LC; Bergmann-Leitner ES; Jain P
J Extracell Biol; 2023 Jul; 2(7):. PubMed ID: 37547182
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.
Clements DM; Crumley B; Chew GM; Davis E; Bruhn R; Murphy EL; Ndhlovu LC; Jain P
Front Immunol; 2021; 12():608890. PubMed ID: 33767694
[TBL] [Abstract][Full Text] [Related]
4. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
5. Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
Enose-Akahata Y; Vellucci A; Jacobson S
Front Microbiol; 2017; 8():2563. PubMed ID: 29312243
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients.
Forlani G; Baratella M; Tedeschi A; Pique C; Jacobson S; Accolla RS
Front Microbiol; 2019; 10():819. PubMed ID: 31080441
[TBL] [Abstract][Full Text] [Related]
7. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
[TBL] [Abstract][Full Text] [Related]
9. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
10. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules.
Mohammadi A; Fazeli B; Poursina Z; Tehranian F; Vakili V; Boostani R; Rafatpanah H
Med Microbiol Immunol; 2019 Dec; 208(6):835-844. PubMed ID: 31317252
[TBL] [Abstract][Full Text] [Related]
13. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
Yasuma K; Matsuzaki T; Yamano Y; Takashima H; Matsuoka M; Saito M
J Neurovirol; 2016 Aug; 22(4):416-30. PubMed ID: 26635027
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
16. Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes.
Anderson MR; Pleet ML; Enose-Akahata Y; Erickson J; Monaco MC; Akpamagbo Y; Velluci A; Tanaka Y; Azodi S; Lepene B; Jones J; Kashanchi F; Jacobson S
Clin Transl Med; 2018 Aug; 7(1):24. PubMed ID: 30146667
[TBL] [Abstract][Full Text] [Related]
17. Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP Patients.
Mohammadi A; Yazdi SZ; Poursina Z; Hampson IN; Vakili V; Sahebkar A; Akbarien MM; Rahimi H; Vakili R; Boostani R; Rafatpanah H
Adv Exp Med Biol; 2021; 1328():347-359. PubMed ID: 34981488
[TBL] [Abstract][Full Text] [Related]
18. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
[TBL] [Abstract][Full Text] [Related]
19. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
